|Articles|December 1, 2007

Picroliv holds therapeutic potential

Picroliv has demonstrated improved re-epithelialization, neovascularization and migration of endothelial, dermal myofibroblasts and fibroblasts into the wound bed in a rat model. The findings suggest that the compound, derived from a plant that grows in the Himalayas, holds therapeutic potential as a pro-angiogenic agent in wound healing.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME